Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps

Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by type 2 inflammation with accumulation of activated group 2 innate lymphoid cells (ILC2s) and elevation of thymic stromal lymphopoietin (TSLP). A member of the TNF superfamily (TNFSF), TNFSF15, is known to induce the production of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mucosal immunology 2020-01, Vol.13 (1), p.86-95
Hauptverfasser: Ogasawara, Noriko, Poposki, Julie A., Klingler, Aiko I., Tan, Bruce K., Hulse, Kathryn E., Stevens, Whitney W., Peters, Anju T., Grammer, Leslie C., Welch, Kevin C., Smith, Stephanie S., Conley, David B., Raviv, Joseph R., Soroosh, Pejman, Takano, Ken-ichi, Himi, Tetsuo, Kern, Robert C., Schleimer, Robert P., Kato, Atsushi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 95
container_issue 1
container_start_page 86
container_title Mucosal immunology
container_volume 13
creator Ogasawara, Noriko
Poposki, Julie A.
Klingler, Aiko I.
Tan, Bruce K.
Hulse, Kathryn E.
Stevens, Whitney W.
Peters, Anju T.
Grammer, Leslie C.
Welch, Kevin C.
Smith, Stephanie S.
Conley, David B.
Raviv, Joseph R.
Soroosh, Pejman
Takano, Ken-ichi
Himi, Tetsuo
Kern, Robert C.
Schleimer, Robert P.
Kato, Atsushi
description Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by type 2 inflammation with accumulation of activated group 2 innate lymphoid cells (ILC2s) and elevation of thymic stromal lymphopoietin (TSLP). A member of the TNF superfamily (TNFSF), TNFSF15, is known to induce the production of type 2 cytokines in ILC2s. Although ILC2s have been implicated in CRSwNP, the presence and role of TNFSFs in ILC2-mediated type 2 inflammation in CRSwNP has not been elucidated. Here, we investigate the involvement of TNFSFs in ILC2-mediated type 2 inflammation in CRSwNP. We found that receptor activator of NF-κB (RANK) ligand (RANK-L (TNFSF11)) was significantly elevated in nasal polyps (NPs), and that the receptor of RANK-L, RANK, was expressed on ILC2s in human peripheral blood and NPs. An agonistic antibody against RANK induced production of type 2 cytokines in human ILC2s, and TSLP significantly enhanced this reaction. The membrane-bound RANK-L was detected mainly on CD45 + immune cells, including T H 2 cells in NPs. The co-culture of NP-derived ILC2s and T H 2 cells significantly enhanced production of type 2 cytokines, and anti-RANK-L monoclonal antibody suppressed this enhancement. In conclusion, RANK-L, together with TSLP, may play an inductive role in the ILC2-mediated type 2 inflammation in CRSwNP.
doi_str_mv 10.1038/s41385-019-0215-8
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6917894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2327331059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-f21b4bfc2c27c1cc3e4aabe54b6e72f11180c4d92b78c5997ecf42ca453d73323</originalsourceid><addsrcrecordid>eNp9kUtv1TAQhSNERR_wA9ggS2zYhHr8iO0NUnUFpeKqSBWsLcdxel0ldrCTVvff49tbykOiK491vjkzo1NVrwG_B0zlaWZAJa8xqBoT4LV8Vh2BorymjDfP72u6U9RhdZzzDcYNxpy-qA4pNAwIpUfV7VUcHIo9ujq7_FKvkcnIoCnOLszeDMiHbrEu7YCL9YrUo-u8mV2H5u3kECl6P5hxNLOPoXyQ3aQYvEVp40PMPizZzz6jOz9vUDC5OE5x2E75ZXXQmyG7Vw_vSfX908dvq8_1-uv5xepsXVum5Fz3BFrW9pZYIixYSx0zpnWctY0TpAcAiS3rFGmFtFwp4WzPiDWM005QSuhJ9WHvOy1t2d2Ws5IZ9JT8aNJWR-P130rwG30db3WjQEjFisG7B4MUfywuz3r02bphMMHFJWtCsQRB5f2st_-gN3FJoZynCRMcU2CNeJKipCwNmKtCwZ6yKeacXP-4MmC9y17vs9cle73LXsvS8-bPWx87foVdALIHcpHCtUu_R__f9SeG7LnU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2327331059</pqid></control><display><type>article</type><title>Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ogasawara, Noriko ; Poposki, Julie A. ; Klingler, Aiko I. ; Tan, Bruce K. ; Hulse, Kathryn E. ; Stevens, Whitney W. ; Peters, Anju T. ; Grammer, Leslie C. ; Welch, Kevin C. ; Smith, Stephanie S. ; Conley, David B. ; Raviv, Joseph R. ; Soroosh, Pejman ; Takano, Ken-ichi ; Himi, Tetsuo ; Kern, Robert C. ; Schleimer, Robert P. ; Kato, Atsushi</creator><creatorcontrib>Ogasawara, Noriko ; Poposki, Julie A. ; Klingler, Aiko I. ; Tan, Bruce K. ; Hulse, Kathryn E. ; Stevens, Whitney W. ; Peters, Anju T. ; Grammer, Leslie C. ; Welch, Kevin C. ; Smith, Stephanie S. ; Conley, David B. ; Raviv, Joseph R. ; Soroosh, Pejman ; Takano, Ken-ichi ; Himi, Tetsuo ; Kern, Robert C. ; Schleimer, Robert P. ; Kato, Atsushi</creatorcontrib><description>Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by type 2 inflammation with accumulation of activated group 2 innate lymphoid cells (ILC2s) and elevation of thymic stromal lymphopoietin (TSLP). A member of the TNF superfamily (TNFSF), TNFSF15, is known to induce the production of type 2 cytokines in ILC2s. Although ILC2s have been implicated in CRSwNP, the presence and role of TNFSFs in ILC2-mediated type 2 inflammation in CRSwNP has not been elucidated. Here, we investigate the involvement of TNFSFs in ILC2-mediated type 2 inflammation in CRSwNP. We found that receptor activator of NF-κB (RANK) ligand (RANK-L (TNFSF11)) was significantly elevated in nasal polyps (NPs), and that the receptor of RANK-L, RANK, was expressed on ILC2s in human peripheral blood and NPs. An agonistic antibody against RANK induced production of type 2 cytokines in human ILC2s, and TSLP significantly enhanced this reaction. The membrane-bound RANK-L was detected mainly on CD45 + immune cells, including T H 2 cells in NPs. The co-culture of NP-derived ILC2s and T H 2 cells significantly enhanced production of type 2 cytokines, and anti-RANK-L monoclonal antibody suppressed this enhancement. In conclusion, RANK-L, together with TSLP, may play an inductive role in the ILC2-mediated type 2 inflammation in CRSwNP.</description><identifier>ISSN: 1933-0219</identifier><identifier>EISSN: 1935-3456</identifier><identifier>DOI: 10.1038/s41385-019-0215-8</identifier><identifier>PMID: 31641233</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Allergology ; Antibodies ; Biomedical and Life Sciences ; Biomedicine ; CD45 antigen ; Cell culture ; Cells, Cultured ; Chronic Disease ; Cytokines ; Cytokines - metabolism ; Female ; Gastroenterology ; Helper cells ; Humans ; Immunity, Innate ; Immunology ; Inflammation ; Inflammation - immunology ; Lymphocytes - immunology ; Lymphocytes T ; Lymphoid cells ; Male ; Middle Aged ; Monoclonal antibodies ; Nasal Polyps - immunology ; NF-κB protein ; Peripheral blood ; Polyps ; RANK Ligand - metabolism ; Rhinitis ; Rhinitis - immunology ; Rhinosinusitis ; Sinusitis ; Sinusitis - immunology ; Th2 Cells - immunology ; Th2 Cells - metabolism ; Thymic stromal lymphopoietin ; Thymus ; TRANCE protein ; Tumor necrosis factor ; Young Adult</subject><ispartof>Mucosal immunology, 2020-01, Vol.13 (1), p.86-95</ispartof><rights>Society for Mucosal Immunology 2019</rights><rights>Copyright Nature Publishing Group Jan 2020</rights><rights>Society for Mucosal Immunology 2019.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-f21b4bfc2c27c1cc3e4aabe54b6e72f11180c4d92b78c5997ecf42ca453d73323</citedby><cites>FETCH-LOGICAL-c498t-f21b4bfc2c27c1cc3e4aabe54b6e72f11180c4d92b78c5997ecf42ca453d73323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31641233$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ogasawara, Noriko</creatorcontrib><creatorcontrib>Poposki, Julie A.</creatorcontrib><creatorcontrib>Klingler, Aiko I.</creatorcontrib><creatorcontrib>Tan, Bruce K.</creatorcontrib><creatorcontrib>Hulse, Kathryn E.</creatorcontrib><creatorcontrib>Stevens, Whitney W.</creatorcontrib><creatorcontrib>Peters, Anju T.</creatorcontrib><creatorcontrib>Grammer, Leslie C.</creatorcontrib><creatorcontrib>Welch, Kevin C.</creatorcontrib><creatorcontrib>Smith, Stephanie S.</creatorcontrib><creatorcontrib>Conley, David B.</creatorcontrib><creatorcontrib>Raviv, Joseph R.</creatorcontrib><creatorcontrib>Soroosh, Pejman</creatorcontrib><creatorcontrib>Takano, Ken-ichi</creatorcontrib><creatorcontrib>Himi, Tetsuo</creatorcontrib><creatorcontrib>Kern, Robert C.</creatorcontrib><creatorcontrib>Schleimer, Robert P.</creatorcontrib><creatorcontrib>Kato, Atsushi</creatorcontrib><title>Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps</title><title>Mucosal immunology</title><addtitle>Mucosal Immunol</addtitle><addtitle>Mucosal Immunol</addtitle><description>Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by type 2 inflammation with accumulation of activated group 2 innate lymphoid cells (ILC2s) and elevation of thymic stromal lymphopoietin (TSLP). A member of the TNF superfamily (TNFSF), TNFSF15, is known to induce the production of type 2 cytokines in ILC2s. Although ILC2s have been implicated in CRSwNP, the presence and role of TNFSFs in ILC2-mediated type 2 inflammation in CRSwNP has not been elucidated. Here, we investigate the involvement of TNFSFs in ILC2-mediated type 2 inflammation in CRSwNP. We found that receptor activator of NF-κB (RANK) ligand (RANK-L (TNFSF11)) was significantly elevated in nasal polyps (NPs), and that the receptor of RANK-L, RANK, was expressed on ILC2s in human peripheral blood and NPs. An agonistic antibody against RANK induced production of type 2 cytokines in human ILC2s, and TSLP significantly enhanced this reaction. The membrane-bound RANK-L was detected mainly on CD45 + immune cells, including T H 2 cells in NPs. The co-culture of NP-derived ILC2s and T H 2 cells significantly enhanced production of type 2 cytokines, and anti-RANK-L monoclonal antibody suppressed this enhancement. In conclusion, RANK-L, together with TSLP, may play an inductive role in the ILC2-mediated type 2 inflammation in CRSwNP.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Allergology</subject><subject>Antibodies</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>CD45 antigen</subject><subject>Cell culture</subject><subject>Cells, Cultured</subject><subject>Chronic Disease</subject><subject>Cytokines</subject><subject>Cytokines - metabolism</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Helper cells</subject><subject>Humans</subject><subject>Immunity, Innate</subject><subject>Immunology</subject><subject>Inflammation</subject><subject>Inflammation - immunology</subject><subject>Lymphocytes - immunology</subject><subject>Lymphocytes T</subject><subject>Lymphoid cells</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Monoclonal antibodies</subject><subject>Nasal Polyps - immunology</subject><subject>NF-κB protein</subject><subject>Peripheral blood</subject><subject>Polyps</subject><subject>RANK Ligand - metabolism</subject><subject>Rhinitis</subject><subject>Rhinitis - immunology</subject><subject>Rhinosinusitis</subject><subject>Sinusitis</subject><subject>Sinusitis - immunology</subject><subject>Th2 Cells - immunology</subject><subject>Th2 Cells - metabolism</subject><subject>Thymic stromal lymphopoietin</subject><subject>Thymus</subject><subject>TRANCE protein</subject><subject>Tumor necrosis factor</subject><subject>Young Adult</subject><issn>1933-0219</issn><issn>1935-3456</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtv1TAQhSNERR_wA9ggS2zYhHr8iO0NUnUFpeKqSBWsLcdxel0ldrCTVvff49tbykOiK491vjkzo1NVrwG_B0zlaWZAJa8xqBoT4LV8Vh2BorymjDfP72u6U9RhdZzzDcYNxpy-qA4pNAwIpUfV7VUcHIo9ujq7_FKvkcnIoCnOLszeDMiHbrEu7YCL9YrUo-u8mV2H5u3kECl6P5hxNLOPoXyQ3aQYvEVp40PMPizZzz6jOz9vUDC5OE5x2E75ZXXQmyG7Vw_vSfX908dvq8_1-uv5xepsXVum5Fz3BFrW9pZYIixYSx0zpnWctY0TpAcAiS3rFGmFtFwp4WzPiDWM005QSuhJ9WHvOy1t2d2Ws5IZ9JT8aNJWR-P130rwG30db3WjQEjFisG7B4MUfywuz3r02bphMMHFJWtCsQRB5f2st_-gN3FJoZynCRMcU2CNeJKipCwNmKtCwZ6yKeacXP-4MmC9y17vs9cle73LXsvS8-bPWx87foVdALIHcpHCtUu_R__f9SeG7LnU</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Ogasawara, Noriko</creator><creator>Poposki, Julie A.</creator><creator>Klingler, Aiko I.</creator><creator>Tan, Bruce K.</creator><creator>Hulse, Kathryn E.</creator><creator>Stevens, Whitney W.</creator><creator>Peters, Anju T.</creator><creator>Grammer, Leslie C.</creator><creator>Welch, Kevin C.</creator><creator>Smith, Stephanie S.</creator><creator>Conley, David B.</creator><creator>Raviv, Joseph R.</creator><creator>Soroosh, Pejman</creator><creator>Takano, Ken-ichi</creator><creator>Himi, Tetsuo</creator><creator>Kern, Robert C.</creator><creator>Schleimer, Robert P.</creator><creator>Kato, Atsushi</creator><general>Nature Publishing Group US</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200101</creationdate><title>Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps</title><author>Ogasawara, Noriko ; Poposki, Julie A. ; Klingler, Aiko I. ; Tan, Bruce K. ; Hulse, Kathryn E. ; Stevens, Whitney W. ; Peters, Anju T. ; Grammer, Leslie C. ; Welch, Kevin C. ; Smith, Stephanie S. ; Conley, David B. ; Raviv, Joseph R. ; Soroosh, Pejman ; Takano, Ken-ichi ; Himi, Tetsuo ; Kern, Robert C. ; Schleimer, Robert P. ; Kato, Atsushi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-f21b4bfc2c27c1cc3e4aabe54b6e72f11180c4d92b78c5997ecf42ca453d73323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Allergology</topic><topic>Antibodies</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>CD45 antigen</topic><topic>Cell culture</topic><topic>Cells, Cultured</topic><topic>Chronic Disease</topic><topic>Cytokines</topic><topic>Cytokines - metabolism</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Helper cells</topic><topic>Humans</topic><topic>Immunity, Innate</topic><topic>Immunology</topic><topic>Inflammation</topic><topic>Inflammation - immunology</topic><topic>Lymphocytes - immunology</topic><topic>Lymphocytes T</topic><topic>Lymphoid cells</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Monoclonal antibodies</topic><topic>Nasal Polyps - immunology</topic><topic>NF-κB protein</topic><topic>Peripheral blood</topic><topic>Polyps</topic><topic>RANK Ligand - metabolism</topic><topic>Rhinitis</topic><topic>Rhinitis - immunology</topic><topic>Rhinosinusitis</topic><topic>Sinusitis</topic><topic>Sinusitis - immunology</topic><topic>Th2 Cells - immunology</topic><topic>Th2 Cells - metabolism</topic><topic>Thymic stromal lymphopoietin</topic><topic>Thymus</topic><topic>TRANCE protein</topic><topic>Tumor necrosis factor</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ogasawara, Noriko</creatorcontrib><creatorcontrib>Poposki, Julie A.</creatorcontrib><creatorcontrib>Klingler, Aiko I.</creatorcontrib><creatorcontrib>Tan, Bruce K.</creatorcontrib><creatorcontrib>Hulse, Kathryn E.</creatorcontrib><creatorcontrib>Stevens, Whitney W.</creatorcontrib><creatorcontrib>Peters, Anju T.</creatorcontrib><creatorcontrib>Grammer, Leslie C.</creatorcontrib><creatorcontrib>Welch, Kevin C.</creatorcontrib><creatorcontrib>Smith, Stephanie S.</creatorcontrib><creatorcontrib>Conley, David B.</creatorcontrib><creatorcontrib>Raviv, Joseph R.</creatorcontrib><creatorcontrib>Soroosh, Pejman</creatorcontrib><creatorcontrib>Takano, Ken-ichi</creatorcontrib><creatorcontrib>Himi, Tetsuo</creatorcontrib><creatorcontrib>Kern, Robert C.</creatorcontrib><creatorcontrib>Schleimer, Robert P.</creatorcontrib><creatorcontrib>Kato, Atsushi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Mucosal immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ogasawara, Noriko</au><au>Poposki, Julie A.</au><au>Klingler, Aiko I.</au><au>Tan, Bruce K.</au><au>Hulse, Kathryn E.</au><au>Stevens, Whitney W.</au><au>Peters, Anju T.</au><au>Grammer, Leslie C.</au><au>Welch, Kevin C.</au><au>Smith, Stephanie S.</au><au>Conley, David B.</au><au>Raviv, Joseph R.</au><au>Soroosh, Pejman</au><au>Takano, Ken-ichi</au><au>Himi, Tetsuo</au><au>Kern, Robert C.</au><au>Schleimer, Robert P.</au><au>Kato, Atsushi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps</atitle><jtitle>Mucosal immunology</jtitle><stitle>Mucosal Immunol</stitle><addtitle>Mucosal Immunol</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>13</volume><issue>1</issue><spage>86</spage><epage>95</epage><pages>86-95</pages><issn>1933-0219</issn><eissn>1935-3456</eissn><abstract>Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by type 2 inflammation with accumulation of activated group 2 innate lymphoid cells (ILC2s) and elevation of thymic stromal lymphopoietin (TSLP). A member of the TNF superfamily (TNFSF), TNFSF15, is known to induce the production of type 2 cytokines in ILC2s. Although ILC2s have been implicated in CRSwNP, the presence and role of TNFSFs in ILC2-mediated type 2 inflammation in CRSwNP has not been elucidated. Here, we investigate the involvement of TNFSFs in ILC2-mediated type 2 inflammation in CRSwNP. We found that receptor activator of NF-κB (RANK) ligand (RANK-L (TNFSF11)) was significantly elevated in nasal polyps (NPs), and that the receptor of RANK-L, RANK, was expressed on ILC2s in human peripheral blood and NPs. An agonistic antibody against RANK induced production of type 2 cytokines in human ILC2s, and TSLP significantly enhanced this reaction. The membrane-bound RANK-L was detected mainly on CD45 + immune cells, including T H 2 cells in NPs. The co-culture of NP-derived ILC2s and T H 2 cells significantly enhanced production of type 2 cytokines, and anti-RANK-L monoclonal antibody suppressed this enhancement. In conclusion, RANK-L, together with TSLP, may play an inductive role in the ILC2-mediated type 2 inflammation in CRSwNP.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>31641233</pmid><doi>10.1038/s41385-019-0215-8</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1933-0219
ispartof Mucosal immunology, 2020-01, Vol.13 (1), p.86-95
issn 1933-0219
1935-3456
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6917894
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Aged, 80 and over
Allergology
Antibodies
Biomedical and Life Sciences
Biomedicine
CD45 antigen
Cell culture
Cells, Cultured
Chronic Disease
Cytokines
Cytokines - metabolism
Female
Gastroenterology
Helper cells
Humans
Immunity, Innate
Immunology
Inflammation
Inflammation - immunology
Lymphocytes - immunology
Lymphocytes T
Lymphoid cells
Male
Middle Aged
Monoclonal antibodies
Nasal Polyps - immunology
NF-κB protein
Peripheral blood
Polyps
RANK Ligand - metabolism
Rhinitis
Rhinitis - immunology
Rhinosinusitis
Sinusitis
Sinusitis - immunology
Th2 Cells - immunology
Th2 Cells - metabolism
Thymic stromal lymphopoietin
Thymus
TRANCE protein
Tumor necrosis factor
Young Adult
title Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A20%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20RANK-L%20as%20a%20potential%20inducer%20of%20ILC2-mediated%20type%202%20inflammation%20in%20chronic%20rhinosinusitis%20with%20nasal%20polyps&rft.jtitle=Mucosal%20immunology&rft.au=Ogasawara,%20Noriko&rft.date=2020-01-01&rft.volume=13&rft.issue=1&rft.spage=86&rft.epage=95&rft.pages=86-95&rft.issn=1933-0219&rft.eissn=1935-3456&rft_id=info:doi/10.1038/s41385-019-0215-8&rft_dat=%3Cproquest_pubme%3E2327331059%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2327331059&rft_id=info:pmid/31641233&rfr_iscdi=true